Latest News

BD Collaborates with Mayo Clinic for De-Identified Patient Data Access

Through this new partnership, BD intends to leverage the de-identified patient data to improve its medical devices and meet patient needs.

Source: Getty Images

By Sarai Rodriguez

- BD (Becton, Dickinson, and Company) recently announced a new partnership with Mayo Clinic, gaining the health IT vendor access to de-identified patient data from Mayo Clinic Platform_Discover to develop medical devices that meet patient needs.

The Mayo Clinic Platform_Discover, a product of Mayo Clinic Platform, holds robust de-identified data sets from 10 million patients, including nearly 1.2 billion lab test results, 3 million echocardiograms, and more than 640 million clinical notes.

By using data mining, artificial intelligence (AI), and machine learning tools, BD will analyze the real-world data , which provides information outside what is usually collected in a clinical trial, the press release stated. This real-world data will allow the health IT vendor to gain deeper insight into the patient experience, helping the company fuel innovation around unmet patient needs, BD stated.